{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=HAV&page=10", "query": { "intervention": "HAV", "page": 10 }, "page_size": 10 }, "pagination": { "page": 10, "page_size": 10, "total_count": 1228, "total_pages": 123, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=HAV&page=11&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=HAV&page=9&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T22:21:46.859Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02503735", "title": "Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hepatitis C", "Chronic Kidney Disease" ], "interventions": [ { "name": "Sofosbuvir/Ledipasvir FDC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14, "start_date": "2015-07-15", "completion_date": "2019-05", "has_results": true, "last_update_posted_date": "2020-01-13", "last_synced_at": "2026-10-21T22:21:46.859Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02503735" }, { "nct_id": "NCT02881762", "title": "Maraviroc Efficacy for Hepatitis C", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hepatitis C", "Human Immunodeficiency Virus" ], "interventions": [ { "name": "Maraviroc", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2017-06-01", "completion_date": "2019-03-27", "has_results": true, "last_update_posted_date": "2024-05-01", "last_synced_at": "2026-10-21T22:21:46.859Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02881762" }, { "nct_id": "NCT01591668", "title": "A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hepatitis C" ], "interventions": [ { "name": "Single Ascending Dose Cohorts GS-9620", "type": "DRUG" }, { "name": "Multiple Ascending Dose Cohorts GS-9620", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 51, "start_date": "2012-03", "completion_date": "2012-12", "has_results": false, "last_update_posted_date": "2013-08-13", "last_synced_at": "2026-10-21T22:21:46.859Z", "location_count": 10, "location_summary": "Little Rock, Arkansas • DeLand, Florida • Orlando, Florida + 7 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "DeLand", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Berlin", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01591668" }, { "nct_id": "NCT00978497", "title": "Safety, Tolerability, and Antiviral Activity of ANA598 Administered in Combination With Pegylated Interferon and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HCV Infection" ], "interventions": [ { "name": "placebo", "type": "DRUG" }, { "name": "ANA598", "type": "DRUG" }, { "name": "Peginterferon", "type": "DRUG" }, { "name": "Ribavirin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 97, "start_date": "2009-09", "completion_date": "2011-08", "has_results": false, "last_update_posted_date": "2017-03-31", "last_synced_at": "2026-10-21T22:21:46.859Z", "location_count": 20, "location_summary": "Anaheim, California • Los Angeles, California • San Clemente, California + 17 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Clemente", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00978497" }, { "nct_id": "NCT03530124", "title": "Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Apnea", "Apnea Neonatal", "Prematurity" ], "interventions": [ { "name": "PCV13", "type": "BIOLOGICAL" }, { "name": "DTaP", "type": "BIOLOGICAL" }, { "name": "HBV", "type": "BIOLOGICAL" }, { "name": "IPV", "type": "BIOLOGICAL" }, { "name": "Hib", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": null, "sex": "ALL", "summary": "6 Weeks and older" }, "enrollment_count": 223, "start_date": "2018-07-17", "completion_date": "2021-11-01", "has_results": true, "last_update_posted_date": "2024-02-14", "last_synced_at": "2026-10-21T22:21:46.859Z", "location_count": 4, "location_summary": "Atlanta, Georgia • Chapel Hill, North Carolina • Durham, North Carolina + 1 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03530124" }, { "nct_id": "NCT01350648", "title": "Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hepatitis B", "Hepatitis C", "HIV-HCV Co-Infection" ], "interventions": [], "intervention_types": [], "sponsor": "National Institutes of Health Clinical Center (CC)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 569, "start_date": "2011-08-23", "completion_date": "2022-03-17", "has_results": false, "last_update_posted_date": "2024-10-01", "last_synced_at": "2026-10-21T22:21:46.859Z", "location_count": 2, "location_summary": "Washington D.C., District of Columbia • Bethesda, Maryland", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01350648" }, { "nct_id": "NCT04398706", "title": "Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pneumococcal Immunisation", "Diphtheria Immunisation", "Tetanus Immunisation", "Pertussis Immunisation", "Hepatitis B Immunisation", "Haemophilus Influenzae Type b Immunisation", "Polio Immunisation", "Measles Immunisation", "Rubella Immunisation", "Varicella Immunisation", "Mumps Immunisation" ], "interventions": [ { "name": "Pneumococcal Conjugate Vaccine formulation 1", "type": "BIOLOGICAL" }, { "name": "Pneumococcal Conjugate Vaccine formulation 2", "type": "BIOLOGICAL" }, { "name": "Pneumococcal Conjugate Vaccine formulation 3", "type": "BIOLOGICAL" }, { "name": "Varicella Virus Vaccine Live", "type": "BIOLOGICAL" }, { "name": "Measles, Mumps, and Rubella Virus Vaccine Live", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]", "type": "BIOLOGICAL" }, { "name": "Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate)", "type": "BIOLOGICAL" }, { "name": "Rotavirus Vaccine, Live, Oral, Pentavalent", "type": "BIOLOGICAL" }, { "name": "Hepatitis B Vaccine* [Recombinant] *as applicable", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "15 Months", "sex": "ALL", "summary": "42 Days to 15 Months" }, "enrollment_count": 852, "start_date": "2020-05-22", "completion_date": "2023-08-10", "has_results": true, "last_update_posted_date": "2025-09-08", "last_synced_at": "2026-10-21T22:21:46.859Z", "location_count": 49, "location_summary": "Jonesboro, Arkansas • Bellflower, California • Huntington Park, California + 41 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Bellflower", "state": "California" }, { "city": "Huntington Park", "state": "California" }, { "city": "Huntington Park", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04398706" }, { "nct_id": "NCT03224949", "title": "Comparison of ALD, NASH, and Healthy Control Patients", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "ALD - Alcoholic Liver Disease" ], "interventions": [ { "name": "Blood draw", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 500, "start_date": "2017-06-19", "completion_date": "2028-09-30", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-21T22:21:46.859Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03224949" }, { "nct_id": "NCT01329978", "title": "Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hepatitis C, Chronic" ], "interventions": [ { "name": "Sofosbuvir", "type": "DRUG" }, { "name": "RBV", "type": "DRUG" }, { "name": "PEG", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 332, "start_date": "2011-03", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2014-05-26", "last_synced_at": "2026-10-21T22:21:46.859Z", "location_count": 44, "location_summary": "Montgomery, Alabama • Jonesboro, Arkansas • Anaheim, California + 36 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Burbank", "state": "California" }, { "city": "Coronado", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01329978" }, { "nct_id": "NCT04199715", "title": "Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hepatitis B" ], "interventions": [ { "name": "Heplisav-B", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Baylor Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2019-12-03", "completion_date": "2022-01-20", "has_results": false, "last_update_posted_date": "2022-03-11", "last_synced_at": "2026-10-21T22:21:46.859Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04199715" } ] }